JEFFREY FOLICK - 03 Jan 2021 Form 4 Insider Report for Bright Health Group Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Jeffrey Folick, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
03 Jan 2021
Net transactions value
+$35,671
Form type
4
Filing time
30 Jun 2021, 21:25:15 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHG Common Stock Options Exercise $7,135 +11,385 +0.96% $0.6267* 1,196,247 03 Jan 2021 Direct F1
transaction BHG Common Stock Options Exercise $14,268 +22,767 +1.9% $0.6267* 1,219,014 03 Mar 2021 Direct
transaction BHG Common Stock Options Exercise $7,133 +11,382 +0.93% $0.6267* 1,230,396 03 Apr 2021 Direct
transaction BHG Common Stock Options Exercise $7,135 +11,385 +0.93% $0.6267* 1,241,781 03 May 2021 Direct
transaction BHG Common Stock Conversion of derivative security +106,271 +8.6% 1,348,052 28 Jun 2021 Direct F2
transaction BHG Common Stock Conversion of derivative security +92,823 +6.9% 1,440,875 28 Jun 2021 Direct F3
transaction BHG Common Stock Conversion of derivative security +96,237 +6.7% 1,537,112 28 Jun 2021 Direct F3
transaction BHG Common Stock Conversion of derivative security +39,933 +2.6% 1,577,045 28 Jun 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHG Stock Options (Right to Buy) Options Exercise $0 -11,385 -6.3% $0.000000 170,754 03 Jan 2021 Common Stock 11,385 $0.6267 Direct F2
transaction BHG Stock Options (Right to Buy) Options Exercise $0 -22,767 -13% $0.000000 147,987 03 Mar 2021 Common Stock 22,767 $0.6267 Direct F2
transaction BHG Stock Options (Right to Buy) Options Exercise $0 -11,382 -7.7% $0.000000 136,605 03 Apr 2021 Common Stock 11,382 $0.6267 Direct F2
transaction BHG Stock Options (Right to Buy) Options Exercise $0 -11,385 -8.3% $0.000000 125,220 03 May 2021 Common Stock 11,385 $0.6267 Direct F2
transaction BHG Series A Preferred Stock Conversion of derivative security $0 -156,570 -100% $0.000000* 0 28 Jun 2021 Common Stock 106,271 Direct F3
transaction BHG Series B Preferred Stock Conversion of derivative security $0 -30,941 -100% $0.000000* 0 28 Jun 2021 Common Stock 92,823 Direct F4
transaction BHG Series C Preferred Stock Conversion of derivative security $0 -32,079 -100% $0.000000* 0 28 Jun 2021 Common Stock 96,237 Direct F4
transaction BHG Series D Preferred Stock Conversion of derivative security $0 -13,311 -100% $0.000000* 0 28 Jun 2021 Common Stock 39,933 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 1-for-3 forward stock split effected on June 2, 2021.
F2 These stock options vest over four years as follows: (a) 25% vested on April 3, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (of 546,411) vests in monthly installments for the following three years.
F3 Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.
F4 Each share of the Issuer's Preferred Stock Series, B, C and D converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.